欢迎访问西亚试剂!
西亚试剂banner
西亚试剂banner
西亚试剂banner

当前位置:首页 > 新闻中心

西亚试剂:Discovery of a potent benzoxaborole-based anti-pneumococcal

发布时间:2025-07-09

Discovery of a potent benzoxaborole-based anti-pneumococcal agent targeting leucyl-tRNA synthetase

Qing-Hua Hu, Ru-Juan Liu, Zhi-Peng Fang, Jiong Zhang, Ying-Ying Ding, Min Tan, Meng Wang, Wei Pan, Hu-Chen Zhou & En-Duo Wang

 

Streptococcus pneumoniae causes bacterial pneumonia with high mortality and morbidity. The emergency of multidrug-resistant bacteria threatens the treatment of the disease. Leucyl-tRNA synthetase (LeuRS) plays an essential role in cellular translation and is an attractive drug target for antimicrobial development. Here we report the compound ZCL039, a benzoxaborole-based derivative of AN2690, as a potent anti-pneumococcal agent that inhibits S. pneumoniae LeuRS (SpLeuRS) activity. We show using kinetic, biochemical analyses combined with the crystal structure of ZCL039-AMP in complex with the separated SpLeuRS editing domain, that ZCL039 binds to the LeuRS editing active site which requires the presence of tRNALeu, and employs an uncompetitive inhibition mechanism. Further docking models establish that ZCL039 clashes with the eukaryal/archaeal specific insertion I4ae helix within editing domains. These findings demonstrate the potential of benzoxaboroles as effective LeuRS inhibitors for pneumococcus infection therapy, and provide future structure-guided drug design and optimization.

上一篇:西亚试剂:Heteroduplex joint formation free of net topological change
下一篇:西亚试剂:帕金森氏症患者线粒体的消失
版权所有:山东西亚化学有限公司

鲁ICP备20015914号-4